These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12650716)

  • 21. Tissue-specific estrogenic response and molecular mechanisms.
    Diel P
    Toxicol Lett; 2002 Feb; 127(1-3):217-24. PubMed ID: 12052661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct, complex effects of estrogens on basal forebrain cholinergic neurons.
    Bora SH; Liu Z; Kecojevic A; Merchenthaler I; Koliatsos VE
    Exp Neurol; 2005 Aug; 194(2):506-22. PubMed ID: 15893308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptor beta acts as a dominant regulator of estrogen signaling.
    Pettersson K; Delaunay F; Gustafsson JA
    Oncogene; 2000 Oct; 19(43):4970-8. PubMed ID: 11042684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: a perspective.
    Kumar S; Lata K; Mukhopadhyay S; Mukherjee TK
    Biochim Biophys Acta; 2010 Oct; 1800(10):1127-35. PubMed ID: 20434525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What does an orphan G-protein-coupled receptor have to do with estrogen?
    Rae JM; Johnson MD
    Breast Cancer Res; 2005; 7(6):243-4. PubMed ID: 16280047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Both Estrogen and Androgen Modify the Response to Activation of Neurokinin-3 and κ-Opioid Receptors in Arcuate Kisspeptin Neurons From Male Mice.
    Ruka KA; Burger LL; Moenter SM
    Endocrinology; 2016 Feb; 157(2):752-63. PubMed ID: 26562263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotection against oxidative stress by estrogens: structure-activity relationship.
    Behl C; Skutella T; Lezoualc'h F; Post A; Widmann M; Newton CJ; Holsboer F
    Mol Pharmacol; 1997 Apr; 51(4):535-41. PubMed ID: 9106616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rapid effects of estrogen: a mini-review.
    Lokuge S; Frey BN; Foster JA; Soares CN; Steiner M
    Behav Pharmacol; 2010 Sep; 21(5-6):465-72. PubMed ID: 20661136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells.
    Pak TR; Chung WC; Lund TD; Hinds LR; Clay CM; Handa RJ
    Endocrinology; 2005 Jan; 146(1):147-55. PubMed ID: 15471969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors alpha and beta and interactions with cyclic AMP.
    Maharjan S; Serova L; Sabban EL
    J Neurochem; 2005 Jun; 93(6):1502-14. PubMed ID: 15935066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile.
    Zhao L; O'Neill K; Brinton RD
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1124-32. PubMed ID: 16951259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity of ovarian steroid signaling in the hypothalamus.
    Rønnekleiv OK; Kelly MJ
    Front Neuroendocrinol; 2005 Sep; 26(2):65-84. PubMed ID: 16009409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes.
    Segars JH; Driggers PH
    Trends Endocrinol Metab; 2002 Oct; 13(8):349-54. PubMed ID: 12217492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons.
    Zhao L; Wu TW; Brinton RD
    Brain Res; 2004 Jun; 1010(1-2):22-34. PubMed ID: 15126114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mechanisms for estrogen-induced neuroprotection.
    Singh M; Dykens JA; Simpkins JW
    Exp Biol Med (Maywood); 2006 May; 231(5):514-21. PubMed ID: 16636299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mining the complexities of the estrogen signaling pathways for novel therapeutics.
    McDonnell DP
    Endocrinology; 2003 Oct; 144(10):4237-40. PubMed ID: 14500558
    [No Abstract]   [Full Text] [Related]  

  • 37. Estrogen receptor-alpha and neural circuits to the spinal cord during pregnancy.
    Papka RE; Hafemeister J; Puder BA; Usip S; Storey-Workley M
    J Neurosci Res; 2002 Dec; 70(6):808-16. PubMed ID: 12444603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons.
    Sawada H; Shimohama S
    Neurosci Biobehav Rev; 2000 Jan; 24(1):143-7. PubMed ID: 10654671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective activities of estrogen: an update.
    Behl C; Manthey D
    J Neurocytol; 2000; 29(5-6):351-8. PubMed ID: 11424951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordinate regulation of neuropeptide Y and agouti-related peptide gene expression by estrogen depends on the ratio of estrogen receptor (ER) alpha to ERbeta in clonal hypothalamic neurons.
    Titolo D; Cai F; Belsham DD
    Mol Endocrinol; 2006 Sep; 20(9):2080-92. PubMed ID: 16675543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.